soluble il-4 receptor
Recombinant proteinexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 1998 (NCT00017693)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Interleukin-4ANTAGONIST
IL4 antagonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- soluble il-4 receptor
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00017693 | Phase 2 | May 1, 1998 | Immunex, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, University of Virginia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immunex | For profit | 1 | 0 | 1 | 1998 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 1998 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 1998 |
| University of Virginia | Academic/Hospital | 1 | 0 | 1 | 1998 |
4 organizations
Page 1 / 1